But the cells that survive the initial therapy will grow in a highly oxidative niche due to enhanced ROS from PCa cell metabolism and radiotherapy and become dependent on NRF2-mediated antioxidant system to survive. This evidence concerns the gene NFE2L2 and posterior cortical atrophy.